When used with the appropriate medical guidance, GLP-1 medications like Ozempic, Wegovy and Mounjaro can be an effective ...

Seafood protein is gaining serious attention among health experts in the United States for its unmatched quality, ...

"Lean muscle is kind of an oxymoron. All muscle is lean," says Brad Schoenfeld, Ph.D., C.S.C.S., and professor of exercise ...

Many enjoy a fitness "bulking phase" in the winter season. Getting in the gym and lifting more is a great way to spend the year's colder months. However, gaining weight can go wrong, and you find you ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Some patient populations may be at higher risk for lean ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? Anbereen Hasan grew up swimming and dabbled in Pilates as an adult, but she ...

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...

As Miami-based Veru continues development of its enobosarm to prevent muscle wasting in patients being treated for obesity, among other conditions, the biopharma has conducted a survey showing that ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Gabby Landsverk Every time Gabby publishes a story, you’ll get an alert straight to your inbox!

Altimmune, Inc. shares surged nearly 30% after positive Phase 2 clinical study results for pemvidutide, a GLP-1/glucagon dual receptor agonist for obesity and MASH. Pemvidutide may compete with Novo ...